Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
OWNR
L&K BIOMED
★
L&K BIOMED's Largest Shareholder Kang Guk-jin Reports Extension of Pledge and Deposit Agreements with No Change in Stake
07/20/2026 04:12 PM
OWNR
L&K BIOMED
★
Largest Shareholder Kang Guk-jin Slightly Increases Stake to 12.03% via Open Market Purchase by Special Relation, Maintaining Control
07/06/2026 03:44 PM
PERI
L&K BIOMED
★
L&K Biomed Reports Q1 2026 Net Profit Turnaround (Revenue 9.5B Won, OP 0.1B)
05/15/2026 04:03 PM